Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons
Radiofrequency ablation is durable after 2 years, compares favorably with endoscopic resection for advanced disease, and reduces the risk for cancer progression
SUNNYVALE, Calif., June 3 /PRNewswire/ -- Results from a number of clinical trials were presented during the Digestive Disease Wee...
Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples
Data Published in May Issue of Journal of Sexual Medicine
INDIANAPOLIS, May 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-...
Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
NEW ROCHELLE, N.Y., Jan. 29 /PRNewswire/ -- Two common strains of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, were virtually eradicated in the laboratory by exposing them to a wavelength of blue light, in a process called photo-irradiation that is described in a paper pu...
Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
SAN FRANCISCO, Dec. 8 /PRNewswire/ -- Millennium: The Takeda Oncology Company today reported
updated results based on extended follow up of patients from the large, international Phase III VISTA(1) trial showing continued survival improvement for patients with previously untreated multiple myeloma...
Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
NEW YORK, Nov. 20 /PRNewswire/ -- Clinical data from a prospective
registry presented this week at the 35th Annual Veith Symposium shows DVT
treatment with the Trellis(R) Peripheral Infusion System from Bacchus
Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most
Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
SOUTH SAN FRANCISCO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc. (Nasdaq: MGRM ) announced today that data presented this
week demonstrated that in Pfizer Inc's (NYSE: PFE ) phase III trial of
Selzentry(TM) (maraviroc) in treatment naive individuals with CCR5-tropic
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Patients on Treatment Also Experienced Improved Physical Functioning
INDIANAPOLIS, June 13 /PRNewswire-FirstCall/ -- New data suggest that
patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg
Cymbalta (duloxetine HCl) once daily experienced significant pain
Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
EAST SETAUKET, N.Y., April 23 /PRNewswire-FirstCall/ -- Lixte
Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that Dr.
Jie Lu and Dr. Zhengping Zhuang of the Surgical Neurology Branch (SNB),
National Institute of Neurological Disorders and Stroke (NINDS), National
RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial
- CLINICAL TRIAL RESULTS PUBLISHED IN THE JOURNAL OF DERMATOLOGIC SURGERY -
SAN MATEO, Calif., Jan. 14 /PRNewswire-FirstCall/ -- BioForm Medical,
Inc. (Nasdaq: BFRM ) today announced the publication of a post-marketing
multi- center, randomized, blinded comparative study of nasolabial fold
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
SAN MATEO, Calif., Dec. 12 /PRNewswire-FirstCall/ -- BioForm Medical,
Inc. (Nasdaq: BFRM ) today announced the publication of a multi-center,
randomized, blinded comparative study of nasolabial fold treatments
reporting higher patient satisfaction with its Radiesse(R) dermal filler
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
TAXUS IV study demonstrates long-term safety and efficacy of TAXUS drug- eluting stent compared to bare-metal stent
NATICK, Mass., and WASHINGTON, Oct. 22 /PRNewswire-FirstCall/ -- Boston
Scientific Corporation (NYSE: BSX ) today announced five-year and final
follow- up data fro...
New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
CONCORD, Mass., Oct. 2 /PRNewswire/ -- Many studies have suggested that
moderate red wine consumption is beneficial to cardiovascular health. But
what if you'd like to skip the alcohol? Take heart: laboratory research,
just presented at the WINEHEALTH 2007 conference in Bordeaux, France,
Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in
Age-Related Macular Degeneration
TARRYTOWN, N.Y. & LEVERKUSEN, Germany--(BUSINESS WIRE)--Mar 27,
2007 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer
HealthCare AG (NYSE: BAY) today announced positive preliminary data
from a pre-planned interim analysis of a Phase 2 randomized study
of their VEGF Trap-Eye in patient...
Preclinical Data on Cytogen's Technology to be Reported at the AACR
PRINCETON, N.J.--(BUSINESS WIRE)--Mar 29, 2007 - Cytogen
Corporation (NASDAQ: CYTO) today reported
the upcoming presentation
of preclinical data at the 2007 Annual Meeting of the American
Association for Cancer Research (AACR) taking place in Los Angeles,
California April 14-18, 2007. The AACR abst...
CuraGen and TopoTarget Announce New Clinical Results With
Belinostat to be Reported at Upcoming Major Medical Meetings
BRANFORD, Conn., April 19, 2007 /PRNewswire-FirstCall/ --
CuraGen Corporation and TopoTarget A/S announced today that
preliminary interim clinical data on intravenous belinostat
(PXD101), a histone deacetylase (HDAC) inhibitor being investigated
for the treatment of cancer, are expected to be pres...
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 9, 2007 - Regeneron
Pharmaceuticals, Inc. (Nasdaq: REGN) today announced positive
results from several studies evaluating the VEGF Trap-Eye in the
neovascular form of age-related macular degeneration (wet AMD) and
diabetic macular edema (DME). These findi...
ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds
for Solid Tumors Are to be Reported at ASCO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen, Inc.
(Nasdaq: IMGN), a biopharmaceutical company that develops targeted
anticancer therapeutics using its Tumor-Activated Prodrug (TAP)
technology, today announced that clinical findings for three
different TAP compounds for the treatment...
New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting
CHICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Cytogen Corporation
(NASDAQ: CYTO) today reported
results from clinical trials
demonstrating that QUADRAMET (samarium Sm-153 lexidronam injection)
can be safely administered to prostate cancer patients who are also
receiving the chemotherapy docetaxel (Taxote...
Clinical Data Reported on Vidaza in Hematologic Malignancies and
Advanced Solid Tumors
HDAC Inhibitor MGCD0103 Demonstrates substantial Response Rate
in Two Clinical Trials
Clinical Data Presented on Pilot Pharmacokinetic Study of Oral
Exelixis Reports Comprehensive XL880 Phase I Data At ASCO
Exelixis Reports Integrated Data From Phase II Clinical Trials
of XL999 a...
The International Myeloma Foundation Says Data Reported at a Global
Medical Meeting in Greece Demonstrates Improved Survival for a Wide
Range of Myeloma Patients
- Data Presented at the 11th International Myeloma Workshop -
NORTH HOLLYWOOD, Calif., and KOS, Greece, June 29, 2007
/PRNewswire/ -- The International Myeloma Foundation (IMF) --
supporting research and providing education, advocacy and support
for myeloma patients, families, researchers and phys...
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial
Targeting System's Success in Mouse Model Reported in Cancer Cell
HOUSTON, July 9, 2007 - A molecularly engineered
therapy selectively embeds a gene in pancreatic cancer that shrinks
or eradicates tumors, inhibits metastasis, and prolongs survival
with virtually no toxicity, researchers from The University of
Texas M. D. Anderson Cancer Center report in the Jul...
Regular Yoga Practice Is Associated With Mindful Eating
...kely to be obese, according to a study led by researchers at Fred Hutchinson Cancer Research Center.
The study was prompted by initial findings reported
four years ago by Alan Kristal, Dr.P.H., and colleagues, who found that regular yoga practice may help prevent middle-age spread in normal-weight peop...
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
...ccurred in approximately 1 percent of patients. Severe infusion reactions included anaphylactic reactions, bronchospasm, and hypotension. Although not reported
with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Dep...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...ully execute its business strategy and as a result reported
$669,000 of pro forma net income for the quarter e...mprovement over the same period in 2008. Isis also reported
a pro forma net operating loss of $1.3 million for...erolemia (FH) patients; positive top line data was reported
in May 2009
Report data from additional mipo...
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
SAN CARLOS, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) today reported
its financial results for the second quarter ended June 30, 2009.
Net loss for the quarter ended June 30, 2009 was $32.1 million or $0.35 per ...
Study Shows Brain Fitness can Save Medicare Billions
... hours of training over one initial six-week period. Participants have been followed for more than five years.
The ACTIVE study team previously reported
that participants who performed the computerized brain exercises had significantly improved health outcomes, as measured by a widely used instrument a...
Scientists Discover Origin of Malaria
...scovery Could Lead to Development of New Treatments, Prevent Future Plagues
SAN FRANCISCO, Aug. 3 /PRNewswire-USNewswire/ -- Today scientists reported
that they have discovered the origin of malaria, one of the deadliest diseases of humanity. Chimpanzees, native to equatorial Africa, have been identi...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
...-1.04) (secondary endpoint).
Overall, the incidence of adverse events and serious adverse events was consistent with what has previously been reported
for these two agents. Rates of osteonecrosis of the jaw (ONJ) were balanced and infrequent in both treatment groups (10 patients receiving denosumab ...
Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
...venous formulation of TELINTRA were published earlier in the Journal of Hematology and Oncology, 13 May 2009; Vol. 2, No.20, pp. 20-32. The findings reported
from these studies support the further development of TELINTRA. Phase 2 studies are ongoing in MDS (enrollment completion expected by year end), and ...
Project Zero Delay Accelerates Drug's Path to Clinical Trial
...ormally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported
their work in the Journal of Clinical Oncology published online on August 3(rd).
The joint effort, dubbed Project Zero Delay, is part of a ...
TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men
...o increased risk for cardiovascular disease. GH has been found to decrease total body and regional fat mass in older men, while sex-steroids have been reported
to have positive effects on lipid (fat) concentrations in the body.
About Kronos Longevity Research Institute
Kronos Longevity Resear...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...rious side effect that could be fatal and has been reported
with INVEGA((R)) SUSTENNA(TM) and similar medicine...e, but serious and sometimes permanent side effect reported
with INVEGA((R)) SUSTENNA(TM) and similar medicine...ed.
High blood sugar and diabetes have been reported
with INVEGA((R)) SUSTENNA(TM) and similar medicine...
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...lieves that three ProLindac combination trials will start shortly upon regulatory approvals of protocols in both China and Korea. Further, Access has reported
receipt of additional milestone payments from its Far East partners in the ordinary course under their collaborative agreements.
"Our Chinese p...
Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
... global specialty biopharmaceutical company,
positive results from the first of three Phase III...s. "This data are consistent with
those previously reported
from the Phase I/II and extension studies. We will...erated with no
drug-related serious adverse events reported
in the trial. No patients
withdrew from the trial ...
GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip
Liberia has a culture of sexual violence that is a carry-over from years of conflict there.
South Africa has one of the highest reported
rates of rape in the world, coupled with one of the highest HIV rates in the world.
As a U.S. Senator, Secretary Clinton was a co-sponso...
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
PRINCETON, N.J., July 31 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) reported
today positive preliminary results from its phase I clinical trial of PSI-7851 for the treatment of hepatitis C (HCV). PSI-7851 is a second generation...
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
...sease-related biologic pathway using an integrated and innovative array of in vitro readouts and advanced in vivo imaging technologies. The newly reported
biologic pathway relates to monocyte deployment from the spleen to inflammatory sites, including myocardial infarction. The findings are expected to ...
New Powder Speeds Healing of Difficult Foot Wounds
...cers are the leading cause of non-traumatic, lower-limb amputations in the United States. In a recent APMA survey, 18 percent of people with diabetes reported
that they have experienced a foot sore that would not heal. This powder's successful treatment of difficult foot wounds could potentially lead to a re...
Diabetes Gene Raises Odds of Lower Birth Weight
...study co-leader Hakon Hakonarson, Ph.D., director of the Center for Applied Genomics at Children's Hospital, investigated 20 gene locations previously reported
to be associated with type 2 diabetes. Drawing on a cohort of some 5,700 Caucasian children in an ongoing genome-wide association study of childhood o...
Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment
...fe-changing event, this need is seen to a lesser degree than was previously reported
after traditional surgical clipping. The study represents the largest case...res of two other bodies of data, the first being data that was previously reported
in medical literature for surgically clipped patients (at present, there is...